Fate Therapeutics

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell FATE and other ETFs, options, and stocks.

About FATE

Fate Therapeutics, Inc. engages in the development of programmed cellular immunotherapies for cancer and immune disorder. Its pipeline of products includes immuno-ocology candidates and immuno-regulation candidates. 

CEO
Bahram Valamehr
CEOBahram Valamehr
Employees
181
Employees181
Headquarters
San Diego, California
HeadquartersSan Diego, California
Founded
2007
Founded2007
Employees
181
Employees181

FATE Key Statistics

Market cap
128.36M
Market cap128.36M
Price-Earnings ratio
-0.67
Price-Earnings ratio-0.67
Dividend yield
—
Dividend yield—
Average volume
2.44M
Average volume2.44M
High today
$1.17
High today$1.17
Low today
$1.02
Low today$1.02
Open price
$1.03
Open price$1.03
Volume
1.68M
Volume1.68M
52 Week high
$5.92
52 Week high$5.92
52 Week low
$0.6611
52 Week low$0.6611

Analyst ratings

67%

of 12 ratings
Buy
33.3%
Hold
66.7%
Sell
0%
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.